The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen‐stimulated T cells leading to an increase in cell survival
Abstract
OX40 engagement on activated T cells leads to increased proliferation, expansion and survival of Ag‐specific T cells. Direct ex vivo examination of Ag‐stimulated murine T cells show that the Myc antagonists, Mxd4 and Mnt, are transiently upregulated and translocated to the nucleus following OX40 engagement and may be involved in suppressing cell death. Both Mxd4 and Mnt are upregulated following OX40 stimulation through increased protein stability and we identify a critical phosphorylation site in Mxd4 that controls Mxd4 stability. The upregulation of Mxd4 and Mnt contributes to OX40‐mediated T‐cell survival because siRNA knockdown of Mxd4 and Mnt led to increased cell death. We hypothesize the upregulation of c‐Myc following OX40 engagement drives T‐cell proliferation and that upregulation of Mxd4 and Mnt suppresses Myc‐dependent cell death. Thus, Mxd4 and Mnt upregulation following OX40 engagement most likely increases T‐cell survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For efficient and stable training of the model, we put the layer normalization inside the transformer block and thus the gradients were well-behaved at initialization 66 , reducing the hyperparameter tuning cost for the learning rate warm-up stage.”
From Large-scale foundation model on single-cell transcriptomics (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Research works printed but not linked: 63
- 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M · DOI
- Gramaglia I., 1998, Ox‐40 ligand: a potent costimulatory molecule for sustaining primary CD4+ T cell responses, J. Immunol., 161, 6510, 10.4049/jimmunol.161.12.6510 · DOI
- 10.1002/eji.200636428 · DOI
- 10.1016/S0952-7915(99)80046-6 · DOI
- 10.4049/jimmunol.175.6.3534 · DOI
- Hendriks J., 2005, During viral infection of the respiratory tract, CD27, 4‐1BB, and OX40 collectively determine formation of CD8++ memory T cells and their capacity for secondary expansion, J. Immunol., 175, 1665, 10.4049/jimmunol.175.3.1665 · DOI
- 10.1084/jem.180.2.757 · DOI
- 10.4049/jimmunol.177.7.4464 · DOI
- 10.4049/jimmunol.179.11.7244 · DOI
- 10.1006/smim.1998.0146 · DOI
- 10.4049/jimmunol.167.12.6804 · DOI
- 10.4049/jimmunol.180.4.2140 · DOI
- 10.4049/jimmunol.171.11.5997 · DOI
- Weinberg A. D., 1999, Blocking OX‐40/OX‐40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis, J. Immunol., 162, 1818, 10.4049/jimmunol.162.3.1818 · DOI
- 10.1016/0167-5699(94)90080-9 · DOI
- 10.1084/jem.182.2.459 · DOI · Paper page
- 10.1016/S1074-7613(00)80366-0 · DOI
- 10.1146/annurev.cellbio.16.1.653 · DOI · Paper page
- 10.1016/S0378-1119(01)00697-7 · DOI
- 10.1038/314366a0 · DOI
- 10.1002/j.1460-2075.1985.tb03885.x · DOI
- 10.1101/gad.7.11.2110 · DOI
- 10.1007/978-3-642-60801-8_11 · DOI
- 10.1016/S0092-8674(00)81531-7 · DOI
- 10.1016/0092-8674(93)90663-B · DOI
- 10.1101/gad.6.1.71 · DOI
- 10.1016/0092-8674(93)90661-9 · DOI
- 10.1128/MCB.24.4.1560-1569.2004 · DOI
- 10.1074/jbc.275.14.10413 · DOI
- 10.1006/excr.2000.4996 · DOI
- 10.1083/jcb.200411013 · DOI
- 10.1038/90633 · DOI
- 10.1016/j.immuni.2004.06.004 · DOI
- 10.1002/j.1460-2075.1988.tb03133.x · DOI
- 10.1002/eji.200737972 · DOI
- 10.1038/414768a · DOI
- 10.1073/pnas.0812255106 · DOI
- 10.1101/gad.313104 · DOI · Paper page
- 10.1189/jlb.1103586 · DOI
- 10.1016/S0014-4827(02)00019-8 · DOI
- 10.1016/S0092-8674(00)80371-2 · DOI
- 10.1038/sj.onc.1206212 · DOI
- 10.1128/MCB.24.10.4294-4308.2004 · DOI
- 10.4049/jimmunol.162.10.5813 · DOI
- 10.1242/jcs.115.15.3039 · DOI
- 10.1615/CritRevImmunol.v18.i5.10 · DOI
- 10.1084/jem.20031058 · DOI
- 10.4049/jimmunol.173.5.3002 · DOI
- 10.4049/jimmunol.172.8.4821 · DOI
- 10.4049/jimmunol.168.2.661 · DOI
- 10.1101/gad.11.1.44 · DOI
- 10.1073/pnas.0802785105 · DOI
- Blair P. J., 1998, CTLA‐4 ligation delivers a unique signal to resting human CD4+ T cells that inhibits interleukin‐2 secretion but allows Bcl‐X(L) induction, J. Immunol., 160, 12, 10.4049/jimmunol.160.1.12 · DOI
- 10.1172/JCI27856 · DOI
- 10.1038/sj.onc.1203508 · DOI
- Carding S., 1987, c‐myc gene expression and activation of human thymocytes, Thymus, 10, 219
- 10.1016/j.ccr.2008.10.018 · DOI · Paper page
- 10.1128/MCB.21.3.703-712.2001 · DOI
- 10.1038/nature03845 · DOI
- Mitchell K. O., 2000, Bax is a transcriptional target and mediator of c‐myc‐induced apoptosis, Cancer Res., 60, 6318
- 10.1128/MCB.26.6.2080-2092.2006 · DOI
- 10.1016/S1074-7613(01)00191-1 · DOI
- 10.1084/jem.157.4.1149 · DOI
Cited by
Sorted by citations
Large-scale foundation model on single-cell transcriptomics
Hao, M., Gong, J., Zeng, X., Liu, C., Guo, Y., Cheng, X., Wang, T., Ma, J., Zhang, X., & Song, L. (2024) · Nature Methods · doi:10.1038/s41592-024-02305-7 · Cited by 628
Large Scale Foundation Model on Single-cell Transcriptomics
Hao, M., Gong, J., Zeng, X., Liu, C., Guo, Y., Cheng, X., Wang, T., Ma, J., Song, L., & Zhang, X. (2023) · doi:10.1101/2023.05.29.542705 · Cited by 639
Metadata
- Authors
- Vasilevsky, N. A., Ruby, C. E., Hurlin, P. J., & Weinberg, A. D.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2011-03-14
- Volume
- 41
- Issue
- 4
- Pages
- 1024-1034
- ISSN
- 0014-2980
- 1521-4141
- PMC
- PMC3575515
- Cited by
- 19
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review